Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia. - Test2 - elhamkhani - TriplyDB

Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia.

Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia.

http://www.wikidata.org/entity/Q33223171

about

Mild cognitive impairment. Part 2: Biological markers for diagnosis and prediction of dementia in Alzheimer's disease Peptide fingerprinting of Alzheimer's disease in cerebrospinal fluid: identification and prospective evaluation of new synaptic biomarkers Biomarkers in the diagnosis of Alzheimer's disease: are we ready?Biological markers for anxiety disorders, OCD and PTSD - a consensus statement. Part I: Neuroimaging and genetics.CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia Classification of genes and putative biomarker identification using distribution metrics on expression profiles Alteration of Aβ metabolism-related molecules in predementia induced by AlCl3 and D-galactose Diagnosis and biomarkers of predementia in Alzheimer's disease.Decreased CSF transferrin in sCJD: a potential pre-mortem diagnostic test for prion disorders.Sensitivity and specificity of diagnostic accuracy in Alzheimer's disease: a synthesis of existing evidence.Measuring Compounds in Exhaled Air to Detect Alzheimer's Disease and Parkinson's Disease.Biomarkers for early diagnosis of Alzheimer disease: 'ALZheimer ASsociated gene'--a new blood biomarker?Perfusion Imaging with SPECT in the Era of Pathophysiology-Based Biomarkers for Alzheimer's Disease.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of Alzheimer's disease and other dementias.Use of proteomic methods in the analysis of human body fluids in Alzheimer research.What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 2: chronic progressive and relapsing disease.Tau as a biomarker of neurodegenerative diseases.Multiple comorbid neuropathologies in the setting of Alzheimer's disease neuropathology and implications for drug development.Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.Changes in methylation patterns of multiple genes from peripheral blood leucocytes of Alzheimer's disease patients.Decreased circulating CD34+ stem cells in early Alzheimer's disease: Evidence for a deficient hematopoietic brain support?Neurocognitive disorders: cluster 1 of the proposed meta-structure for DSM-V and ICD-11.Levels of 17β-Hydroxysteroid Dehydrogenase Type 10 in Cerebrospinal Fluid of People with Mild Cognitive Impairment and Various Types of Dementias.Biomarker research in Parkinson's disease: objective measures needed for patient stratification in future cause-directed trials.Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study.Serum amyloid a protein in clinical cancer diagnosis.Effects of ferrofluid and phytoalexin spirobrassinin on thioflavin-T-based fluorescence in cerebrospinal fluid of the elderly and multiple sclerosis patients.Biomarker identification for diagnosis of Alzheimer's disease.

P2860

Q27027319-2E2844C6-11D5-4D27-964A-280AB4F3D36A Q28477629-0C0766C9-C136-4C40-B85B-CC6BF0ED9FA5 Q31050728-3AB95BB8-AF1A-42F4-96B7-C9F0646D60EE Q31114020-36A76AB8-3E9A-4FC1-A41C-CCE7232CAB48 Q33239180-BA323853-7FD2-4E27-B98F-A8F00973F49C Q33530123-EDE24FF5-83ED-438F-9A84-955027AD1612 Q33617218-53980117-7C05-4B71-92AC-8D117AEE88D8 Q33777509-6852262D-EBAD-4B5E-AAE7-D44DF6BACB11 Q33847248-C5756BF1-12C7-47EF-A663-CB3015BD863F Q34728483-C1455D27-C886-4464-BF53-E440646C0F37 Q35846547-4896B899-52C7-41FE-9399-F86F7B8640D6 Q37118083-E37EC089-8818-4C57-A705-C0FBA062ACDB Q37825442-B01815F0-5F9D-4340-A706-1CA529F06569 Q37834619-08D38B52-3A23-43DA-9B47-48176206EF60 Q38060574-F005D95C-83E3-4D65-A44D-9282A0C44A41 Q38088747-15BB5C3F-C76D-4920-B236-C9974DB1C55D Q40065021-CD9B8D48-2C96-4966-891A-E265E6088A7D Q42656279-17B84A8D-1808-42F3-B082-D2B3DF7CC1B6 Q47587631-AD20CB0C-7891-4257-AFCB-9CEEAA81819C Q48104839-A2CDD96C-9A16-4B74-96B4-04591756B6E8 Q48399015-6D9957A2-97B8-4DDB-BB65-C36604208BD5 Q48445053-9463CCC1-B68F-43B6-AE7E-DC5D446E7668 Q50563468-BD376049-D131-4BF4-B012-217A0D270515 Q51787088-E02DC8CC-B29B-4987-9492-38B2133BC04D Q51872146-9F332C73-CBE2-4938-AB6D-F5C31C49F86C Q53282038-4FCBE20D-14AF-49DB-80AB-15FB80ABB94D Q53352976-9321E399-4473-4158-AFF0-7620020412EB Q53480286-F096810E-F442-4B5C-9DF0-8EBED6B19CF4

P2860

Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia.

http://www.wikidata.org/entity/Q33223171

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

name

Consensus paper of the WFSBP T ...... rential diagnosis of dementia.

@ast

Consensus paper of the WFSBP T ...... rential diagnosis of dementia.

@en

type

label

Consensus paper of the WFSBP T ...... rential diagnosis of dementia.

@ast

Consensus paper of the WFSBP T ...... rential diagnosis of dementia.

@en

prefLabel

Consensus paper of the WFSBP T ...... rential diagnosis of dementia.

@ast

Consensus paper of the WFSBP T ...... rential diagnosis of dementia.

@en

P1433

Q33223171-1F822634-1FA3-4E5A-9977-2ACA911550EB

P1476

Q33223171-6C4457BB-7C9C-49DF-A446-ED03A7D6DC13

P2093

Q33223171-1976F0E8-FF56-4576-8538-1462E6A5276F

Q33223171-201DD2D2-3EEF-47F1-9D0B-ED0FC4467BE7

Q33223171-2639CAE9-1BE0-4BC8-B54A-2011B6D23822

Q33223171-5B2C25D3-33F3-454F-AC93-3E2CC96256CA

Q33223171-89FC3A1E-D14A-477F-B900-0FFB98B39AB4

Q33223171-A3AC053E-5433-4FB6-9A37-B2AF09C5B79B

Q33223171-A9E45610-BE53-42FF-B6F4-61FDD0C6F658

Q33223171-B81CA6E6-7364-4231-9DD9-543E6A9EA09D

Q33223171-DDE8AF0C-9315-4BDC-A66E-15CD6A196EF6

Q33223171-E2413495-20D3-4AC4-A72C-6646CDEFA7D5

P2860

Q33223171-08EC4D0A-6C72-4822-A451-3CCA33A9C628

Q33223171-08FCB059-0F10-44E6-8B8E-16EBC53F2DDA

Q33223171-093FCE16-B569-4B5A-89BE-8A264DD32A26

Q33223171-0A04FF60-DEF6-4FD4-9AFB-BD650F84CCE6

Q33223171-0C601CDC-7D85-4A5E-991F-ED4AAEA960F4

Q33223171-0D019625-2154-45D3-AF2F-068F0B0FA22E

Q33223171-0EC0B06E-9235-4733-826C-7107517FDAB1

Q33223171-1020E40A-C937-4DC9-9966-02AD374423D2

Q33223171-141F4B66-C4BB-4229-AEC3-0CBC6274D52E

Q33223171-18939ADE-028D-4E58-944E-5D47113F1D4D

P304

Q33223171-19E17C24-E97C-466F-9B57-339C90AAB844

P31

Q33223171-C9D2FA93-D5A7-405F-B3A8-C718A3B4005B

P356

Q33223171-4AF9B4E1-688D-438E-8C1C-A6C26DF6BA02

P433

Q33223171-4895C607-0960-4992-8A50-F0E4EE22CADB

P478

Q33223171-46E97B29-B62B-4596-A08F-3FBC52D18AAA

P50

Q33223171-3464A406-7559-4992-AE13-F16AA1878AC4

Q33223171-3A50B884-6F9A-458A-B9FF-46AFDEE30304

Q33223171-4632D050-FEDC-45F7-B1B2-99019F2B2483

Q33223171-632A207B-A0A3-4016-91A9-BFD39F47D447

P577

Q33223171-AF426F2A-8069-401F-AD72-77D013AAFDA2

P5875

Q33223171-1D22DFC3-4E50-4573-A6B2-FC3F94C88AF3

P698

Q33223171-31FA9A4C-02BE-4AF4-A6C3-A3AB9311E183

P921

Q33223171-913D1781-9E8D-42D3-8799-77F9E7ADFD77

P356

15622970510029786

P1433

World Journal of Biological Psychiatry

P1476

Consensus paper of the WFSBP T ...... erential diagnosis of dementia

@en

P2093

A W Henkel

http://www.w3.org/2001/XMLSchema#string

C Hock

http://www.w3.org/2001/XMLSchema#string

D Galasko

http://www.w3.org/2001/XMLSchema#string

H Esselmann

http://www.w3.org/2001/XMLSchema#string

H Hampel

http://www.w3.org/2001/XMLSchema#string

H Vanderstichele

http://www.w3.org/2001/XMLSchema#string

K Iqbal

http://www.w3.org/2001/XMLSchema#string

L Lannfelt

http://www.w3.org/2001/XMLSchema#string

M Otto

http://www.w3.org/2001/XMLSchema#string

P Lewczuk

http://www.w3.org/2001/XMLSchema#string

P2860

Lyme disease: a neuropsychiatric illness

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

Neuropathological stageing of Alzheimer-related changes

Mild cognitive impairment: clinical characterization and outcome

Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism

Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease

Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules

Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography

Platelet monoamine oxidase B and plasma beta-phenylethylamine in Parkinson's disease

Altered microtubule organization in small-calibre axons of mice lacking tau protein

P304

69-84

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/15622970510029786

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Johannes Kornhuber

Edna Grünblatt

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7607310

http://www.w3.org/2001/XMLSchema#string

P698

16156480

http://www.w3.org/2001/XMLSchema#string

P921